neoadjuvant PD-L1 blockade
Showing 9951 - 9975 of >10,000
Renal Carcinoma Metastatic Trial in Italy (Axitinib Oral Tablet, Avelumab)
Recruiting
- Renal Carcinoma Metastatic
- Axitinib Oral Tablet
- Avelumab
-
Monserrato, Cagliari, Italy
- +19 more
Jan 5, 2021
Hypertension, Cardiovascular Diseases, Vascular Diseases Trial in Chicago (Aerobic Training, Resistance Training)
Recruiting
- Hypertension
- +2 more
- Aerobic Training
- Resistance Training
-
Chicago, IllinoisUniversity of Illinois at Chicago
Oct 31, 2022
Intestinal Metabolic Reprogramming asKey Mechanism of Gastric
Active, not recruiting
- Obesity
- +4 more
-
Pittsburgh, PennsylvaniaMagee-Womens Hospital of UPMC
Aug 2, 2022
Type 1 Diabetes Trial in Worldwide (Insulin glargine,300 U/mL, Insulin glargine (100 units /mL), Background therapy)
Completed
- Type 1 Diabetes Mellitus
- Insulin glargine,300 U/mL
- +2 more
-
Tucson, Arizona
- +106 more
Mar 15, 2022
Anesthesia Intubation Complication Trial in Charlottesville (propofol)
Completed
- Anesthesia Intubation Complication
-
Charlottesville, VirginiaUniversity of Virginia Health System
Jan 19, 2021
Melanoma, Renal Carcinoma, Urothelial Carcinoma Trial in China (JS004, a recombinant humanized, IgG4? mAb (mAb) specific to B-
Recruiting
- Melanoma
- +2 more
- JS004, a recombinant humanized, IgG4κ monoclonal antibody (mAb) specific to B- and T-lymphocyte attenuator (BTLA); Toripalimab Injection
-
Fuzhou, Fujian, China
- +10 more
Aug 23, 2021
Patient Research Cohort: Rapidly Evolving Multiple Sclerosis
Completed
- Relapsing-remitting Multiple Sclerosis
- Secondary Progressive Multiple Sclerosis
-
London, United KingdomImperial College NHS Trust
Feb 11, 2021
Spinal Muscular Atrophy Trial in Canada, United States (Placebo, Reldesemtiv 150 mg, Reldesemtiv 450 mg)
Completed
- Spinal Muscular Atrophy
- Placebo
- +2 more
-
Los Angeles, California
- +18 more
Aug 21, 2020
Periodontitis Trial in Viña Del Mar (Lactose tab, Omega 3)
Completed
- Periodontitis
- Lactose tab
- Omega 3
-
Viña Del Mar, Valparaíso, ChileUniversidad Nacional Andres Bello
May 19, 2020
Parkinson Disease, Orthostatic Hypotension Trial in London (Abdominal Strengthening Exercise)
Active, not recruiting
- Parkinson Disease
- Orthostatic Hypotension
- Abdominal Strengthening Exercise
-
London, Ontario, CanadaUniversity Hospital
Feb 17, 2021
Cancer, Hematological Malignancy Trial in New York (Pembrolizumab, Ruxolitinib)
Withdrawn
- Cancer
- Hematological Malignancy
-
New York, New YorkNew York University School of Medicine
May 26, 2020
Metabolic Syndrome Trial in University Park (Yogurt smoothie with BB-12, Yogurt smoothie)
Recruiting
- Metabolic Syndrome
- Yogurt smoothie with BB-12
- Yogurt smoothie
-
University Park, PennsylvaniaThe Pennsylvania State University
Dec 12, 2021
Parkinson Disease, Gait Disorders, Neurologic Trial in Shanghai (Sacral Nerve Stimulation)
Unknown status
- Parkinson Disease
- Gait Disorders, Neurologic
- Sacral Nerve Stimulation
-
Shanghai, Shanghai, ChinaFunctional neurosurgery of Shanghai jiaotong university affiliat
Oct 21, 2019
Physical Exercise Intervention in Breast Cancer Patients at Risk
Recruiting
- Breast Cancer
-
Aberdeen, Aberdeenshire, United KingdomCardiovascular Research Facility
Sep 29, 2021
Plasmodium Vivax Infection Trial in Bangkok (An inoculum of malaria parasitised red blood cells with whole dose blood-stage
Recruiting
- Plasmodium Vivax Infection
- An inoculum of malaria parasitised red blood cells with whole dose blood-stage inoculum
- +3 more
-
Bangkok, ThailandFaculty of Tropical Medicine
Jun 21, 2022
lncRNA NEAT1 in Alleviating Acute Respiratory Distress Syndrome
Enrolling by invitation
- Acute Respiratory Distress Syndrome
- Inflammation
- no intervention
-
Beijing, Beijing, ChinaDepartment of Respiratory and Critical Care Medicine, Beijing An
Jun 16, 2021
Breast Cancer Trial in Worldwide (Amcenestrant-matching , SAR439859, Palbociclib)
Active, not recruiting
- Breast Cancer
- Amcenestrant-matching placebo
- +5 more
-
Daphne, Alabama
- +299 more
May 5, 2022
Rectal Cancer Trial in Shanghai (Capecitabine (Xeloda) Pharmacogenetic Test Reagents, irinotecan, IMRT)
Not yet recruiting
- Rectal Cancer
- Capecitabine (Xeloda) Pharmacogenetic Test Reagents
- +5 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Cencer
Jun 27, 2020
Chronic Low Back Pain Trial in Germany (Exposure therapy, Cognitive behavioral therapy)
Recruiting
- Chronic Low Back Pain
- Exposure therapy
- Cognitive behavioral therapy
-
Landau, RLP, Germany
- +4 more
Jan 11, 2023
Covid-19 Trial in Nigeria (Antioxidation Therapy, Standard of Care)
Withdrawn
- Covid-19
- Antioxidation Therapy
- Standard of Care
-
Umuahia, Abia State, Nigeria
- +10 more
Oct 29, 2021
Advanced Solid Tumors Trial in Philadelphia (interferon-gamma and nivolumab)
Completed
- Advanced Solid Tumors
- interferon-gamma and nivolumab
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Nov 26, 2019